Granite Point Capital Management, L.P. - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 33 filers reported holding DIAMEDICA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Granite Point Capital Management, L.P. ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$1,687,000
-69.6%
184,380
-66.3%
0.06%
-77.8%
Q4 2020$5,545,000
+102.2%
546,855
-15.5%
0.28%
+90.6%
Q3 2020$2,743,000
-17.1%
646,855
+35.5%
0.15%
-11.3%
Q2 2020$3,307,000
+147.5%
477,2300.0%0.17%
-77.7%
Q1 2020$1,336,000
+21.2%
477,230
+110.0%
0.76%
+339.0%
Q4 2019$1,102,000
+134.5%
227,2300.0%0.17%
+132.4%
Q3 2019$470,000
-58.8%
227,230
-1.2%
0.07%
-3.9%
Q2 2019$1,141,000229,9700.08%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 275,000$1,103,0000.40%
Manatuck Hill Partners, LLC 273,100$1,095,0000.38%
Stonepine Capital Management, LLC 165,775$665,0000.30%
Ikarian Capital, LLC 311,041$1,247,0000.09%
COOPERMAN LEON G 200,000$802,0000.04%
Jump Financial, LLC 18,300$73,0000.01%
Shay Capital LLC 10,000$40,0000.01%
Newbridge Financial Services Group, Inc. 1,510$6,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 30,904$124,0000.00%
Patriot Financial Group Insurance Agency, LLC 1,300$5,0000.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders